Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Back to Jobs

SAN DIEGO , Aug. 04, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today reported financial results for the quarter ended June 30, 2016 and

Apply Now